EYE nationalvision.com: Rasio rega marang prakiraan pendapatan

Tandha merek America's Best Contacts & Eyeglasses (EYE)

The difficulty of expanding the physical network due to personnel and rental costs is putting pressure on National Vision Holdings (EYE) quotes. The forward P/S valuation demonstrates price dynamics where 0.50 serves as the base parameter value. The company's fundamentals have been weakened by online competition and the loss of major contracts, however, the current operational pivot through the development of proprietary clinics and digitalization should stabilize the business model.

National Vision - Multiplikator Forward P/S EYE (periode 04.07.2022 - 17.11.2026)

Rincian metrik komprehensif lan analitis National Vision (EYE)

- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:America's Best Contacts & Eyeglasses EYE
Produk sing diprodhuksi nationalvision.com

The integration of optometry and in-house lens production at National Vision Holdings (EYE) creates significant business value, which is reflected in the forward P/S ratio of 0.50. This indicator compares market capitalization with expected revenue, allowing investors to assess whether the asset is overbought or if there is potential for price growth provided the current pace of ecosystem expansion continues.

Analisis perusahaan pesaing

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Progyny Inc (PGNY)|Ardent Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Select Medical Corp SEM|ASTH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan MD|USPH (US Physical Therapy Inc) - Multiplikator Forward P/S|PNTG: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rega forward marang dodolan|Multiplikator Forward P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|EOLS - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MDWD|Rasio rega marang prakiraan pendapatan biote Corp.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep thejoint.com JYNT|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan P3 Health PIII|Multiplikator Forward P/S GANX (Gain Therapeutics Inc.)|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)